Share capital development


Since Xbrane Biopharma was formed in 2008, the share capital has changed according to what is indicated by the table below.

DateTransactionChange number of shares Total number of shares Change share capital Total share capital
2020-11-13Directed share issue2,919,70822,200,415654,5584,977,023
2020-06-16New share issue11,70919,280,7072,6254,322,465
2020-05-29 Directed share issue 3,853,799 19,268,998 863 968 4,319,840
2019-07-25 New share issue 2,720,328 15,415,199 609,8593,455,872
2019-06-27 New share issue 4,387,745 12,694,871983,671 2,846,013
2019-04-05 New share issue 1,977,887 8,307,126443,4151,862,342
2018-04-24 Conversion of convertible loan 330,6126,329,23974,119 1,418,927
2018-04-24 New share issue 41,8575,998,6279,3841,344,808
2017-09-25 New share issue 16,500 5,956,770 3,6991,335,425
2017-06-16 Conversion of convertible loan 528,9865,940,270118,5911,331,725
2017-06-05 New share issue 655,7385,411,284 147,0071,213,134
2016-10-31 Conversion of convertible loan 132,232 4,755,54629,6441,066,127
2016-01-22 New share issue 2,393,0244,623,314536,4831,036,483
2015-12-02 Bonus issue 2,230,290399,100500,000
2015-12-02 Split 10:1 2,230,290100,899
2015-03-11 New share issue 1,989223,029900100,899
2014-02-10 Split 10:1 221,040100,000
2014-02-10 New share issue 11,05222,10450,000100,000
2013-07-22 Share capital decrease approval 50,000
2013-05-15 Share capital decrease 11,052-355,200 50,000
2013-04-25 Share capital decrease 11,052-700,000 405,200
2013-04-25 New share issue 9,824 11,052 982,4001,105,200